CELL MATRIX INC has a total of 24 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are TEGENERO AG, INATHERYS and UBIPROTEIN CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Canada | 2 | |
#5 | New Zealand | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | China | 1 | |
#8 | Hong Kong | 1 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Huse William D | 15 |
#2 | Tang Ying | 14 |
#3 | Broek Daniel | 14 |
#4 | Watkins Jeffry D | 14 |
#5 | Brooks Peter C | 11 |
#6 | Freimark Bruce | 7 |
#7 | Brooks Peter | 5 |
#8 | Van Epps Dennis | 5 |
#9 | Clark Derek | 5 |
#10 | Ying Tang | 1 |
Publication | Filing date | Title |
---|---|---|
AU2007258262A1 | Denatured collagen peptides and uses thereof | |
AU2006283174A1 | Combination therapies for inhibiting integrin-extracellular matrix interactions | |
NZ546359A | Humanised collagen antibodies and related methods | |
US2008050388A1 | Humanized collagen antibodies and related methods | |
US7365167B2 | Humanized collagen antibodies and related methods |